151 related articles for article (PubMed ID: 22039329)
1. Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia.
Ahmad F; Hamzah NA; Mustaffa N; Gan SH
World J Gastroenterol; 2011 Sep; 17(36):4130-4. PubMed ID: 22039329
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A vaccination in chronic liver disease: is it really required in a tropical country like India?
Joshi N; Rao S; Kumar A; Patil S; Rani S
Indian J Med Microbiol; 2007 Apr; 25(2):137-9. PubMed ID: 17582184
[TBL] [Abstract][Full Text] [Related]
4. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.
Zhu Y; Yuan Z; Zhao Q; Chen G; Xu B
Epidemiol Infect; 2013 Mar; 141(3):556-62. PubMed ID: 22687628
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
Özden HT
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930
[TBL] [Abstract][Full Text] [Related]
7. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.
Kim DY; Ahn SH; Lee HW; Kim SU; Kim JK; Paik YH; Lee KS; Han KH; Chon CY
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):923-6. PubMed ID: 18049159
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
10. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.
Jindal M; Rana SS; Gupta RK; Das K; Kar P
Indian J Med Res; 2002 Jan; 115():1-4. PubMed ID: 12424929
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis A infection in patients with chronic viral liver disease: a cross-sectional study in Jahrom, Iran.
Ahmadi Vasmehjani A; Javeshghani D; Baharlou R; Shayestehpour M; Mousavinasab SD; Joharinia N; Enderami SE
Epidemiol Infect; 2015 Feb; 143(3):534-9. PubMed ID: 24742346
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-HAV among patients with chronic viral liver disease.
Cho HC; Paik SW; Kim YJ; Choi MS; Lee JH; Koh KC; Yoo BC; Son HJ; Kim SW
World J Gastroenterol; 2011 Jan; 17(2):236-41. PubMed ID: 21245998
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology of hepatitis A in patients with chronic liver disease.
Saab S; Lee C; Shpaner A; Ibrahim AB
J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
[TBL] [Abstract][Full Text] [Related]
16. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
[TBL] [Abstract][Full Text] [Related]
18. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
[TBL] [Abstract][Full Text] [Related]
19. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
[TBL] [Abstract][Full Text] [Related]
20. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]